2015
DOI: 10.5966/sctm.2014-0235
|View full text |Cite
|
Sign up to set email alerts
|

Adipose Stromal Cells Repair Pressure Ulcers in Both Young and Elderly Mice: Potential Role of Adipogenesis in Skin Repair

Abstract: More than 2.5 million patients in the U.S. require treatment for pressure ulcers annually, and the elderly are at particularly high risk for pressure ulcer development. Current therapy for pressure ulcers consists of conservative medical management for shallow lesions and aggressive debridement and surgery for deeper lesions. The current study uses a murine model to address the hypothesis that adipose-derived stromal/stem cell (ASC) treatment would accelerate and enhance pressure ulcer repair. The dorsal skin … Show more

Help me understand this report

Search citation statements

Order By: Relevance

Paper Sections

Select...
2
1
1
1

Citation Types

6
60
0
2

Year Published

2016
2016
2020
2020

Publication Types

Select...
4
3
1

Relationship

2
6

Authors

Journals

citations
Cited by 67 publications
(68 citation statements)
references
References 43 publications
6
60
0
2
Order By: Relevance
“…We performed immunohistochemical analysis of burn wounds 7 days after initial injury to quantify the number of blood vessels (≥ 20 μm in diameter) in the regenerating tissue (Figure ). Consistent with existing literature on cutaneous ASCs therapies and our previous findings, ASCs delivery within P‐fibrin scaffold leads to enhanced local angiogenesis of the regenerating burn wound. This finding is not surprising, given the ability of ASCs to persist in the wound area for up to two weeks and their pro‐angiogenic/granulation tissue promoting secretory profile after culture in P‐fibrin gel (Supporting Information Figure 2) and in response to cytokines in burn wound exudates …”
Section: Resultssupporting
confidence: 92%
See 2 more Smart Citations
“…We performed immunohistochemical analysis of burn wounds 7 days after initial injury to quantify the number of blood vessels (≥ 20 μm in diameter) in the regenerating tissue (Figure ). Consistent with existing literature on cutaneous ASCs therapies and our previous findings, ASCs delivery within P‐fibrin scaffold leads to enhanced local angiogenesis of the regenerating burn wound. This finding is not surprising, given the ability of ASCs to persist in the wound area for up to two weeks and their pro‐angiogenic/granulation tissue promoting secretory profile after culture in P‐fibrin gel (Supporting Information Figure 2) and in response to cytokines in burn wound exudates …”
Section: Resultssupporting
confidence: 92%
“…To quantify infiltrating mononuclear cells we have used color deconvolution followed by quantification of the dark purple stain. 17 According to our data, P-fibrin treated groups exhibited significant increases in wound cellularity at 7 days post injury. These data are consistent with the known ability of thrombin and fibrinogenderived peptides to recruit monocytes and macrophages.…”
Section: P-fibrin Leads To Enhanced Granulation Tissue Formation One supporting
confidence: 51%
See 1 more Smart Citation
“…Thereafter, they were cultured in adipogenic media (AdipoQual™; LaCell LLC; New Orleans, LA; n = 3), and osteogenic media (10 nM dexamethasone, 20 mM β-glycerophosphate, and 50 μM L-ascorbic acid; n = 3) for 28 days, with the media being replaced every 2-3 days. Adipogenic and osteogenic differentiations were assessed by Oil Red O and Alizarin Red staining, respectively, according to previously described methods [31,32].…”
Section: Differentiationmentioning
confidence: 99%
“…The application of ASCs in wound repair and tissue regeneration has been shown in a number of experimental models both in vitro and in vivo (62). Application of ASCs significantly accelerated the re-epithelialization of cutaneous wounds by promoting human dermal fibroblast proliferation through direct cell-cell contact or through paracrine secretion of a variety of growth factors including bFGF and TGF-β (63, 64). Furthermore, these ASCs differentiate into adipocytes to provide a supportive architecture for dermal regeneration and re-epithelialization (65).…”
Section: Mesenchymal Stem Cellsmentioning
confidence: 99%